Metraipolis › archive › dc_df985073f675

Acceptable respondent burden in patient-reported outcome (PRO) assessment in oncology clinical trials: a mixed methods study with patients and trialists — Europe PMC PMID:41712138

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41712138
DOI
10.1186/s41687-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-05T15:37:32.054Z
SHA-256 of the archived text
5ce0d2422b48b6c8280a807dc97e2b9df308ceab5e9cb43aa92142952694828c
Stable URL of this page
https://metraipolis.com/documento/dc_df985073f675

How to cite

Acceptable respondent burden in patient-reported outcome (PRO) assessment in oncology clinical trials: a mixed methods study with patients and trialists — Europe PMC PMID:41712138 — Europe PMC (en), https://europepmc.org/article/MED/41712138 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df985073f675 (Metraipolis archive dc_df985073f675, sha256 5ce0d2422b48b6c8280a807dc97e2b9df308ceab5e9cb43aa92142952694828c)
BibTeX
@misc{dcdf985073f675,
  title = {Acceptable respondent burden in patient-reported outcome (PRO) assessment in oncology clinical trials: a mixed methods study with patients and trialists — Europe PMC PMID:41712138},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41712138},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df985073f675; sha256 5ce0d2422b48b6c8280a807dc97e2b9df308ceab5e9cb43aa92142952694828c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41712138. Agents can read the archived copy with the MCP tool read_document.